$HHSE_NEWS:..Worldwide-Streaming-Revenues for WILDFIRE

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks hotforpenny #5998
57
$HHSE_NEWS:..Worldwide-Streaming-Revenues for WILDFIRE Drive-Record-Results for Hannover-House
 
Earnings Announcement
 
OTC Disclosure & News Service | 08/14/2026
 
https://www.otcmarkets.com/stock/HHSE/news/Wo...?id=531842

(Click on link to view Tabulated Revenues)

Q2 Revenues Jump and Profits Grow 16-X; HHSE management calls it the beginning of a major resurgence for the 33-year-old independent media company.

Los Angeles, California - A fifty-year-old hit song has delivered the first bona-fide audience hit for indie distributor Hannover House, Inc. (OTC: HHSE). "Wildfire: The Legend of the Cherokee Ghost Horse" – a family appeal feature film based on the number 1 worldwide hit song by Michael Martin Murphey – has connected with streaming audiences worldwide, and positively impacted the company's revenues. Sales for the quarter ending June 30, 2026 jumped to $485,290 as compared to $99,730 for the same quarter last year; while bottom line profits surged to $400,810, an increase of more than 16-X over profits of $25,484 for the June 30, 2025 period.

"This is just the beginning of a new revenue cycle for Hannover House," said Eric Parkinson, C.E.O. "Viewership of the film through streaming platforms worldwide continues to grow, and should result in consistent growth over the next few quarters. While we’re very happy with the current activity for 'Wildfire', we believe that the higher stature productions now underway for Hannover House will ultimately return many millions more in revenue."

Current productions for Hannover House include the Oscar-caliber historic epic, "The 17N Conspiracy," based on the true story of the democratic revolution in Greece in the 1970s. This high-profile production will be Hannover’s locomotive entry for revenue results and awards-consideration in 2027. Other productions for the company include the historic western, "Indian Territory," and the anthology of Native American-themed short films called "Native Fables." As a follow-up to his 2025 horror-thriller, "Unholy Song," writer-director Arthur G. Night has partnered with Hannover House on an ambitious Christmas thriller called "Jolly," which is now in post-production and set for a theatrical and streaming launch later this year. The company is also in pre-production for a $22-million sci-fi adventure to shoot in Malta called "Tempus Porta."

In addition to Hannover House facilitated feature productions, the company will also be releasing several acquisitions to theatres and streaming. "Sinatra: Eternity" was acquired at Cannes from Crisis Cinema and chronicles the life and career of Frank Sinatra as prompted by a writer interviewing the legend. "Sexbot" is a hilarious comedy for our current technological age, from writer-director Ash Baron-Cohen. Hannover House plans a major theatrical campaign for the film around Valentine's Day, 2027.

The company will also promote the release of a political marketing book from best-selling author Barr McClellan starting next week. "American Manifesto: The Winning Campaign Strategies of President Donald J. Trump" goes behind the scenes and deep into the operations of Team Trump in 2024, as they devised and implemented a marketing campaign to emphasize voter hot-button issues, and to fuel the Democratic party leaders into self-sabotage by taking-the-bait on unpopular wedge issues. McClellan feels that the book is a must-read for any campaign strategist, as the information is useful for what to do, and what not to do, for current and upcoming political campaigns.

"Our current results prove the viability of our business strategy," said Parkinson. "Our upcoming release slate will take us to the next level in terms of revenues, assets and profitability. We are thankful for the loyal support of our shareholders, and are happy that we are finally delivering on the results that will fuel a major growth in our stock value," he concluded.

Hannover House was formed in 1993 as Truman Press, Inc., a specialty book publisher. Eric Parkinson purchased the company in 2002 and added DVDs to the company's product offerings. Within just three years, Hannover House grew into a top ten DVD supplier for Walmart Stores, Inc., with significant market presence also earned through Target, Best Buys and thousands of other retail outlets in North America. With the market transition away from physical goods like DVD and BluRay products, Hannover House began placing titles with streaming services, and ultimately, found a working structure for independent products to follow a premium V.O.D. launch window, followed by wide distribution through Advertiser-supported V.O.D. providers (including Tubi and Roku). Higher profile products have also benefitted from the visibility and momentum generated from major market theatrical release windows, which Hannover House expects to become the leading revenue source for the company in 2027 for major features such as "The 17N Conspiracy."

Hannover House also recently resurrected the Hemdale releasing brand, a company for which CEO Eric Parkinson was a principal for many years. Hemdale was one of the most prolific producers and distributors of quality, independent movies from 1967 until 1996, when the impressive film library was sold to MGM-UA. Hit films for Hemdale include "Terminator," "Hoosiers," "Criminal Law", "Impromptu," and Best Picture Academy Award winners "Platoon," and "The Last Emperor." Hemdale also set multiple sales records for home video releases, including chart-topping results for the animated features "Magic Voyage," "The Princess & The Goblin" and "Little Nemo: Adventures In Slumberland." Other Hemdale titles proved to be hugely popular rental videos, including "Savage Land," "Future Shock" and "Grizzly Mountain," all three of which were written and produced by Eric Parkinson. With Hannover's new involvement in higher-profile features, Parkinson said that the timing to resurrect the Hemdale releasing brand felt right.

"We finally have Oscar-caliber projects again," said Parkinson. "Producing and releasing these films under the Hemdale brand is an appropriate nod to the legacy of quality and socially-meritorious content that Hemdale established."

For more information, contact: Alessandra Di Caterino, ADC@Hemdale.us, 332-271-0217
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advocacy for Hiring Disabled Kidney Patients Gains Steam

Updated Category News Views 94

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 5

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
A Game-Changer for Pediatric Diabetes: Novo's Awiqli®

Updated Category News Views 14

Breaking Through the Diabetes Treatment Wall From where I'm sitting, breakthrough approvals like Novo's Awiqli® hit the healthcare landscape with all the subtlety of a freight train. The FDA's green light for Awiqli® as the first once-weekly insulin for kids aged 10 and over with type 2 diabetes is a monumental shift in the treatment paradigm. We're talking about...

Continue Reading
Shanghai and Hamburg Celebrate 40 Years of Collaboration

Updated Category News Views 6

Strengthening the Bond: A Four-Decade Journey With fireworks of diplomacy and cooperation lighting up, Shanghai and Hamburg marked the 40th anniversary of their friendship with an ambition to deepen and broaden ties. These cities, separated by continents but united by their maritime spirit, decided to toast not just the past but also the future. This isn't just some fancy...

Continue Reading
Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

Updated Category News Views 24

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 66

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Astra Security Tackles PHP2Shell Vulnerabilities Head-On

Updated Category News Views 26

Unlocking the PHP Puzzle Hot off the press, Astra Security's stepping up to the plate with some freebie tools designed to sniff out and stamp out those pesky PHP2Shell vulnerabilities—CVE-2026-109618 and CVE-2026-109619. If you're not familiar, these suckers rate a whopping 9.2 on the CVSS v4.0 scale, and that means they got the potential to let remote code execution...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 111

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 5

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading

Top 5 Most Recently Viewed Articles

CoinW Showcases Its Innovations at Taipei Blockchain Week 2024

Updated Category News Views 261

CoinW's Impactful Presence at Taipei Blockchain Week 2024 At the forefront of innovation and security, CoinW, a globally recognized cryptocurrency exchange, recently showcased its vision for the future during Taipei Blockchain Week 2024 as a Gold Sponsor. The event, celebrated for fostering discussions on blockchain advancements, featured the launch of PropW, CoinW's...

Continue Reading
Bank of Åland Plc Seeks Trading Admission of New Covered Bonds

Updated Category News Views 170

Application for Trading Admission of Covered Bonds Bank of Åland Plc, also recognized as Ålandsbanken Abp, is taking an important step by applying for the admission of a new security to trading on Nasdaq Helsinki. This involves their recent issuance of covered bonds, which are highly regarded in the financial market. Details of the Covered Bonds Issue The primary...

Continue Reading
Simpson Manufacturing's Q3 Earnings Report Shows Challenges Ahead

Updated Category News Views 54

Simpson Manufacturing's Third Quarter Performance Simpson Manufacturing Co., Inc. (NYSE: SSD) recently announced its third-quarter earnings, and the results did not meet the expectations of analysts. This disappointing performance resulted in a 5% decline in shares during after-hours trading. The company's focus on producing wood construction products highlights the...

Continue Reading
Alvotech Faces Challenges in Biologics License Approval Process

Updated Category News Views 349

Overview of Biologics License Application Status Alvotech, a prominent biotech firm specializing in biosimilars, has recently updated the market regarding its application status for AVT05, a potential competitor to Simponi (golimumab). The company has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) highlighting certain...

Continue Reading
Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 127

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading